Xyratex, Ltd. (XRTX) was recommended by Kenneth Coleman’s Investment Tracker at $14.52 in Investment Digest issue 707, dated November 16, 2011. The stock has broken down in recent weeks and Coleman now recommends selling.
After a strong advance (of approximately 150%), Coleman also recommends putting Pharmacyclics (PCYC) on “watch” and selling if it breaks below $24.50. PCYC was recommended Kenneth Coleman’s Investment Tracker at $11.28 in Investment Digest issue 703, dated September 14, 2011. PCYC closed yesterday at $28.14.